Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 125
Single User License Price INR 8750
Corporate User License Price USD 375
Corporate User License Price INR 26250
Site License Price USD 250
Site License Price INR 17500
Request a Quote

Report Title

Ablynx NV (ABLX) - Financial and Strategic SWOT Analysis Review

Quote Request for License Type
License Type Price  
Single User License USD 125
Site License USD 250
Enterprise Wide License USD 375
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Ablynx NV (ABLX) - Financial and Strategic SWOT Analysis Review


Quote Request for License Type
License Type Price  
Single User License USD 125
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Ablynx NV (ABLX) - Financial and Strategic SWOT Analysis Review

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Ablynx NV (ABLX) - Financial and Strategic SWOT Analysis Review



Executive Summary

Ablynx NV (ABLX)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Ablynx NV (Ablynx) is a biopharmaceutical company that focuses on developing Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. Nanobodies are a novel class of antibody-derived therapeutic proteins which possess structural and functional properties of naturally-occurring heavy chain only antibodies. It has advantages of conventional antibodies along with the key features of small molecule drugs. Ablynx develops Nanobodies to treat serious human diseases including acquired thrombotic thrombocytopenic purpura (aTTp), psoriasis, bone disorders, cancer and pulmonary diseases. The company has ongoing research collaborations and significant partnerships with key pharmaceutical companies including Merck, Boehringer Ingelheim and Novartis. Ablynx is headquartered in Ghent, Belgium.

Ablynx NV Key Recent Developments

Feb 22,2018: ABLYNX ANNOUNCES 2017 FULL YEAR RESULTS

Feb 07,2018: Ablynx Announces Resignation of Dr Bo Jesper Hansen From the Board of Directors

Jan 24,2018: Ablynx Names Dr Robert Friesen as Chief Scientific Officer

Jan 08,2018: Ablynx Announces Board Changes

Dec 12,2017: Late-Breaking Clinical Trials Signal New Therapeutic Options for Many Patients in the Near Term

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Ablynx NV-Key Facts 6

Ablynx NV-Key Employees 7

Ablynx NV-Key Employee Biographies 8

Ablynx NV-Major Products and Services 10

Ablynx NV-History 11

Ablynx NV-Company Statement 15

Ablynx NV-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Section 2-Company Analysis 17

Company Overview 17

Ablynx NV-Business Description 18

Ablynx NV-Corporate Strategy 19

Ablynx NV-SWOT Analysis 20

SWOT Analysis-Overview 20

Ablynx NV-Strengths 20

Ablynx NV-Weaknesses 21

Ablynx NV-Opportunities 22

Ablynx NV-Threats 23

Ablynx NV-Key Competitors 24

Section 3-Company Financial Ratios 25

Financial Ratios-Capital Market Ratios 25

Financial Ratios-Annual Ratios 26

Performance Chart 28

Financial Performance 28

Financial Ratios-Interim Ratios 29

Financial Ratios-Ratio Charts 30

Section 4-Company's Lifesciences Financial Deals and Alliances 31

Ablynx NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31

Ablynx NV, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32

Ablynx NV, Recent Deals Summary 33

Section 5-Company's Recent Developments 34

Feb 22, 2018: ABLYNX ANNOUNCES 2017 FULL YEAR RESULTS 34

Feb 07, 2018: Ablynx Announces Resignation of Dr Bo Jesper Hansen From the Board of Directors 37

Jan 08, 2018: Ablynx Announces Board Changes 38

Dec 12, 2017: Late-Breaking Clinical Trials Signal New Therapeutic Options for Many Patients in the Near Term 39

Nov 16, 2017: Ablynx Announces Results For The First Nine Months Of 2017 And A Year-To-Date Business Update 43

Oct 06, 2017: Publication In Accordance With Article 14 Of The Belgian Law Of 2 May 2007 Regarding The Publication Of Major Shareholdings (The Transparency Law) 45

Aug 24, 2017: Ablynx Announces 2017 Half Year Results and Year-to-date Business Update 46

Jul 17, 2017: Ablynx Proposes Appointment of Mrs Hilde Windels as a New Independent Director 49

Jul 17, 2017: Ablynx Proposes Appointment of Mrs Hilde Windels as a New Independent Director 50

Jun 13, 2017: Ablynx Appoints Markus Ewert As Chief Business Officer 51

Section 6-Appendix 52

Methodology 52

Ratio Definitions 52

About GlobalData 56

Contact Us 56

Disclaimer 56

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Ablynx NV, Performance Chart (2013-2017) 28

Ablynx NV, Ratio Charts 30

Ablynx NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31

Ablynx NV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 32

List of Tables

Ablynx NV, Key Facts 6

Ablynx NV, Key Employees 7

Ablynx NV, Key Employee Biographies 8

Ablynx NV, Major Products and Services 10

Ablynx NV, History 11

Ablynx NV, Subsidiaries 16

Ablynx NV, Key Competitors 24

Ablynx NV, Ratios based on current share price 25

Ablynx NV, Annual Ratios 26

Ablynx NV, Annual Ratios (Cont...1) 27

Ablynx NV, Interim Ratios 29

Ablynx NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31

Ablynx NV, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32

Ablynx NV, Recent Deals Summary 33

Currency Codes 52

Capital Market Ratios 52

Equity Ratios 53

Profitability Ratios 53

Cost Ratios 54

Liquidity Ratios 54

Leverage Ratios 55

Efficiency Ratios 55

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

VHSquared Ltd.

GlaxoSmithKline Plc

Crescendo Biologics Ltd.

Cell Medica Ltd

Camel-IDs SV/SA.

Ablynx NV, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person